PHARMHE (UK) LTDActive

Company number 08208059Private limited companyIncorporated 2012

Key figures

£162,808+5.8%
Net assets 2024/25
+44.8%
Average annual growth 2019/20–2024/25
050 k100 k150 k200 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, PHARMHE (UK) LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand443,696485,338837,461708,727763,129
Total assets1,158,0482,078,8821,707,9301,943,3142,275,827
Total liabilities1,097,1671,961,4831,543,5711,789,4702,113,019
Net assets / total equity60,881117,399164,359153,844162,808
Average number of employees23555

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: PHARMHE (UK) LTD

Company

PHARMHE (UK) LTD is a private limited company registered with Companies House under company number 08208059. It was incorporated on 10 Sep 2012. Its status is active. The registered office is in Aldermaston (RG7). Its nature of business (SIC 2007) is wholesale of other intermediate products (46760), other business support service activities n.e.c. (82990).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Aug 2025); the company files abridged accounts (unaudited). Net assets were £162,808, up 5.8% on the previous year. Cash at bank and in hand was £763,129. Total assets were £2,275,827 and total liabilities £2,113,019. The company had an average of 5 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 May 2027. The next confirmation statement is due by 19 Aug 2027.